1-[4-[4-Amino-5-(5-fluoro-2-methoxy-benzoyl)-pyrimidin-2-ylamino]-piperidin-1-yl]-2-diethylamino-ethanone

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 1-[4-[4-Amino-5-(5-fluoro-2-methoxy-benzoyl)-pyrimidin-2-ylamino]-piperidin-1-yl]-2-diethylamino-ethanone
• 英文别名: 1-[4-[[4-amino-5-(5-fluoro-2-methoxybenzoyl)pyrimidin-2-yl]amino]piperidin-1-yl]-2-(diethylamino)ethanone
• 化学式: C₂₃H₃₁FN₆O₃
• 分子量: 458.5
• InChiKey: MLMWWSSAARRRSO-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  33
• 可旋转键数：
  9
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.48
• 拓扑面积：
  114
• 氢给体数：
  2
• 氢受体数：
  9

反应信息

• 作为产物：
  描述：

  [4-Amino-2-(piperidin4-ylamino)-pyrimidin-5-yl]-(5-fluoro-2-methoxy-phenyl)-methanone trifluoroacetic acid salt 、 2-二乙氨基乙酸盐酸盐 以to give 1-[4-[4-amino-5-(5-fluoro-2-methoxy-benzoyl)-pyrimidin-2-ylamino]-piperidin-1-yl]-2-diethylamino-ethanone的产率得到1-[4-[4-Amino-5-(5-fluoro-2-methoxy-benzoyl)-pyrimidin-2-ylamino]-piperidin-1-yl]-2-diethylamino-ethanone
  参考文献：
  名称：

  4-aminopyrimidine-5-one derivatives

  摘要：

  揭示了新型中间化合物。这些化合物在合成4-氨基嘧啶-5-酮衍生物中非常有用，这些衍生物抑制细胞周期依赖性激酶，特别是细胞周期依赖性激酶4（Cdk4）。4-氨基嘧啶-5-酮衍生物及其药学上可接受的盐具有抗增殖活性，并且在治疗或控制癌症，特别是实体肿瘤方面非常有用。

  公开号：

  US20060229330A1

文献信息

• 4-Aminopyrimidine-5-one derivatives
  申请人：Hoffmann-La Roche Inc.

  公开号：US07157455B2

  公开（公告）日：2007-01-02

  Novel 4-aminopyrimidine-5-one derivatives are disclosed. These compounds inhibit cyclin-dependent kinases, in particular cyclin-dependent kinase 4 (Cdk4). These compounds and their pharmaceutically acceptable salts and esters have antiproliferative activity and are useful in the treatment or control of cancer, in particular solid tumors. This invention is also directed to pharmaceutical compositions containing such compounds and to methods of treating or controlling cancer, most particularly the treatment or control of breast, lung, colon and prostate tumors. Also disclosed are intermediates useful in the preparation of these novel 4-aminopyrimidine-5-one derivatives.

  本发明披露了新型4-氨基嘧啶-5-酮衍生物。这些化合物抑制细胞周期依赖性激酶，特别是细胞周期依赖性激酶4（Cdk4）。这些化合物及其药学上可接受的盐和酯具有抗增殖活性，并且在治疗或控制癌症，特别是实体瘤方面非常有用。本发明还涉及含有这些化合物的制药组合物以及治疗或控制癌症的方法，特别是乳腺癌、肺癌、结肠癌和前列腺癌的治疗或控制方法。还披露了在制备这些新型4-氨基嘧啶-5-酮衍生物过程中有用的中间体。
• 4-AMINOPYRIMIDINE-5-ONE
  申请人：F.HOFFMANN-LA ROCHE AG

  公开号：EP1628619A2

  公开（公告）日：2006-03-01
• US7157455B2
  申请人：——

  公开号：US7157455B2

  公开（公告）日：2007-01-02
• US7615634B2
  申请人：——

  公开号：US7615634B2

  公开（公告）日：2009-11-10
• [EN] 4-AMINOPYRIMIDINE-5-ONE<br/>[FR] 4-AMINOPYRIMIDINE-5-ONE
  申请人：HOFFMANN LA ROCHE

  公开号：WO2004069139A2

  公开（公告）日：2004-08-19

  Novel 4-aminopyrimidine-5-one derivatives of the formula (I) wherein R1 and R2 are as defined in the specification, are disclosed. These compounds inhibit cyclin-dependent kinases, in particular cyclin-dependent kinase 4 (Cdk4). These compounds and their pharmaceutically acceptable salts and esters have antiproliferative activity and are useful in the treatment or control of cancer, in particular solid tumors. This invention is also directed to pharmaceutical compositions containing such compounds, their use for treating or controlling cancer, to a process of their preparation and to intermediates useful in their preparation.